About Loretta Tse, Ph.D.
Form D filings for CuraSen Therapeutics from 2021 to 2024 list Loretta Tse, Ph.D. as director.
Loretta Tse, Ph.D. first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Loretta Tse, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Loretta Tse, Ph.D. works with at each company, as listed on that company's latest Form D.
CuraSen Therapeutics, Inc. · Form D, Sep 18, 2024
RH
Ron Hunt
Director
AF
Anthony Ford
President and Chief Executive Officer, director
BP
Benjamin Potter
Executive officer
KG
Kathleen Glaub
Director
SD
Simon Tate, Ph.D.
Director
PE
Patrick Enright
Director